Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

Abstract

The use of beta blockers by inpatients with exacerbations of COPD is well tolerated and may be associated with reduced mortality. The potential protective effect of beta blockers in this population warrants further study.